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Leukotrienes are potent cell-derived lipid mediators that play an important
role in allergic and inflammatory reactions (1, 2). Leukotriene B4 (LTB4)' and
its fl hydroxylated metabolite 20-OH LTB4 are highly active chemotactic factors
and interact with specific high-affinity receptors on neutrophils (3-8). Neutro-
phils (PMN) are a potent major source ofLTB4 and other 5-lipoxygenase metab-
olites that are released in large amounts upon stimulation with calcium iono-
phore. Although PMN clearly possess the machinery to produce leukotrienes,
little is known about the regulation of leukotriene synthesis through receptor-
mediated processes (9, 10). In particular, the mechanism of activation of phos-
pholipase A2 in PMN is not known.
In previous studies (10), we found that the 5-lipoxygenase in resting PMN is
an inactive enzyme. Upon stimulation with C5a or FMLP, however, PMN rapidly
and transiently metabolize exogenous arachidonic acid (AA) into leukotrienes.
Thus, the second messengers (i.e., high [Ca21],) generated through the interac-
tion of C5a or FMLP with their respective receptors are sufficient to activate
this enzyme. Indeed, more recent studies (11) on the purified enzyme show a
requirement for high calcium concentration and ATP for activity. However, we
did not find any measurable leukotriene generation from endogenous AA
sources after stimulation with chemotactic factors, in marked contrast to Ca"-
ionophore stimulation. This indicates that the regulation of phospholipase(s)
activation is different from that of lipoxygenase. More recently we found (12)
that the protein kinase C activator PMA rapidly primes PMN to respond to C5a
and FMLP to generate leukotrienes from endogenous AA, albeit at very low
concentration and only within a narrow transient time and concentration-depen-
dent "window."
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LEUKOTRIENE PRODUCTION IN HUMAN NEUTROPHILS
Granulocyte/macrophage colony stimulating factor (GM-CSF) a 18-35-kD
glycopeptide, is a growth factor for myeloid cells produced by antigen-stimu-
lated PBL and stimulated macrophages, endothelial cells, and fibroblasts
(reviewed in references 13, 14) . Its RNA has recently been sequenced and GM-
CSF has been cloned and expressed in monkey cells and Escherichia coli (15-18) .
Interestingly, GM-CSF is not only a growth factor for myeloid precursor cells,
but it also stimulates the effector cell functions ofmature monocytes, PMN, and
eosinophils (14, 19-24) . In the course of our investigations on the influence of
products from stimulated PBL upon neutrophil function, we found that GM-
CSF at physiological concentrations slowly primes PMN to respond to FMLP
and C5a to generate relatively large amounts of 5-Hete, LTB4 , 20-OH LTB4 ,
and 20-000H LTB4 . Neither C5a and FMLP nor GM-CSF alone induce leu-
kotriene synthesis at any time point . The presence or absence of GM-CSF at
inflammatory sites might therefore determine if additional effector cells are
attracted by leukotrienes . In addition, these lipid mediators generated during
cell activation by chemotactic factors might also have an intracellular role and
be responsible for the enhancement of superoxide (02-) generation by GM-
CSF. Our study also shows that pre-exposure of PMN with GM-CSF not only
enhances their response but qualitatively changes the secondary mediator profile
of this effector cell when stimulated with C5a or FMLP .
Materials and Methods
Venous blood was collected from healthy adult donors and PMN were isolated and
described (25) . The cells were suspended at a density of 2-4 X 10'/ml in Dulbecco's
PBS, (Gibco Laboratories, Grand Island, NY) supplemented with 0.5 mg/ml fatty acid-
free BSA (Boehringer, Mannheim, FRG) and 2 mM glucose (DPBS/A) . ThesePMN prep-
arations were essentially free of mononuclear cells (1%, by differential counts) and con-
tained very few platelets, as judged by the fact that ionophore-reacted cells generated
almost no 5S,12S-DiHETE. PMN suspensions (10' cells for RIA only or 5-10 X 10'
cells/batch for HPLC and RIA in HPLC fractions) were incubated at 37 °C in plastic
tubes in a shaking waterbath . Before addition ofGM-CSF, the cells were warmed up for
10 min . Incubation times were as indicated in Results, and the reaction was stopped at
the indicated times by adding 2 vol of methanol .
Mediators.
￿
Lipoxygenase metabolite standards were generated, purified, and charac-
terized exactly as reported in detail in (6, 26) . Synthetic LTB4 , 20-OH LTB4, and 20-
000H LTB4 and LTA4 were a generous gift from Dr . Rockach, Merk-Frosst, Pointe
Claire, Quebec, Canada. FMLP was from Bachem AG (Bubendorf, Switzerland) and was
dissolved in PBS . Human C5a was isolated from yeast-activated human serum as
described previously (27, 28) . GM-CSF was a generous gift from Dr . John F .
DeLamarter, Biogen SA, Geneva, Switzerland . This recombinant Ecoli product has the
same biological profile as the ~lycosilated native factor (17) . The activity of the human
rGM-CSF (rhGM-CSF) was 10 U/mg protein . Units of colony-stimulating activity were
calculated from the linear portion of the dose-response curve, assigning 50 U/ml to the
concentration stimulating the formation of 50% maximal colony numbers (17) . The GM-
CSF used was endotoxin free (<0 .0001 ng endotoxin/1,000 U GM-CSF) . All the neu-
trophil stimuli were stored in small aliquots at -70°C and diluted in assay buffer just
before use .
Lipid Extraction.
￿
After the time indicated, 2 vol of methanol and a constant amount
of internal standard (PGB 2 , Sigma Chemical Co ., St . Louis, MO) were added to the cell
suspension . After 30-60 min at 4°C, aggregated albumin and cell debris were removed
by centrifugation . To this supernatant 2.5 vol of diethyl-ether (Fluka) were added to formDAHINDEN ET AL.
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a monophase. After acidification to pH 3 with 1 N HCI, a biphasic mixture was formed
by the addition of 4 vol of H2O. The organic phase was evaporated to dryness under a
stream of N2, taken up in methanol, and passed through a C18 Sepac extraction column
equilibrated in methanol. The methanol eluent was dried under N2 before dissolving it
in HPLC buffer or RIA assay buffer for HPLC measurements or RIA, respectively.
Recoveries of mono Hete, LTB4, and other DiHete and PGB2 were identical and ranged
routinely between 80 and 95%. The results were corrected according to PGB2 internal
standard recoveries. 20-OH LTB4 and 20-000H LTB4 could be reproducibly recovered
within a range of 38-42% recoveries of that of PGB2 internal standard over the whole
concentration range analyzed in this study. Thus, values of these polar metabolites were
corrected by a factor of 2.5.
HPLC Analysis.
￿
The HPLC system was composed of two Waters Associates (Milford,
MA) model 510 pumps and a Waters Associates automatic gradient controller. Samples
were injected with the use of a U6IK injector (Waters Associates) and the columns (25
X 0,4 cm) and precolumns (5 X 0,4 cm) were thermostated at 35°C with a Waters Asso-
ciates column oven. The stationary phases were Nucleosil C18-100-5 /,m for reverse-
phase HPLC (RP-HPLC) and Nucleosil silica 50-5 um for straight-phase HPLC (SP-
HPLC). The flow rate was always 1 ml/min. The elution of lipids was monitored with a
Spectroflow 783 absorbance detector (Kratos Analytical Instruments, Ramsey, NJ) at 270
nM for trienes and 238 nM for dienes and was programmed for baseline adjustments
and wave length changes at appropriate time intervals. For some experiments, we also
used a diode-array-detector connected to a NEC PC equipped with the appropriate soft-
ware (System 990, all from Waters Associates), which allowed online spectral analysis of
individual peaks of the chromatogram. Data derived from the Spectroflow detector were
stored and analyzed with a Chromato-Integrator D2000 (Merck Hitachi, Tokyo, Japan).
For routine quantitative analysis of lipoxygenase metabolites the following HPLC gra-
dient system was used: Buffer A, water/acetonitrile/tetrahydrofuran/acetic acid
(75 :25:0.15:0 .01); buffer B, acetonitrile/methanol/acetic acid (57 :43 :0.01). Gradient-
program: 0 min initial 100% A, 0% B; 0.01 min 80% A, 20% B; isocratic until 7.5 min,
7.5-8.0 min linear 80% A, 20% B-45% A, 55% B; isocratic until 17.5 min; 17.5-18.0
min linear 45% A, 55% B-25% A, 75% B; isocratic until 27.7 min; 27.7-28.2 min linear
25% A, 75% B to initial. Retention times (in minutes) of a typical RP chromatogram
using this program and solvents were as follows: 20-COOH LTB4: 12 .39 ; 20-OH LTB4:
13.17; 20, 5S,12S-TriHete: 14.06; PGB2: 18.93; 20-OH 12-Hete: 20 .20; 6-trans LTB4;
20.36; 12-epi-6-trans LTB4: 20.66; LTB4: 21 .05; 5S,12S-DiHete: 21 .55; HHT:23.71 ; 5,
6-DiHete: 25.42 and 25.76; 12-0-met: 26.54; 15-Hete: 27.09; 12-Hete: 27 .71, 5-Hete:
28.43 min.
Calculation of Data and Identification of Metabolites.
￿
Approximately every sixth run the
column was calibrated with a mixture of all the lipoxygenase metabolites listed above.
Dose-response curves were established for PGB2, LTB4, and metabolites by doubling the
concentration of compounds of each run. Over the concentration range analyzed in this
study, there was a linear relationship between the amount of compounds injected and
the integrated area of corresponding peaks. The amount of leukotriene was calculated
from the integrated area over baseline, and is expressed in picomoles of lipoxygenase
metabolites generated by 106 PMN. Values from RIA of HPLC fractions were converted
to the same measures using a molecular weight of LTB4 of 336. For RIA (Amersham
Corp., Arlington Heights, IL) of LTB4, 1-ml fractions of the chromatograms were col-
lected, brought to dryness under N2, and suspended in RIA assay buffer. The identity of
PMN-derived lipoxygenase products separated by RP-HPLC was further confirmed by
RP-HPLC and SP-HPLC, UV spectroscopy, and in some cases (20-COOH LTB4, 20-OH
LTB4, LTB4, and 5-Hete), by gas chromatography-mass spectroscopy exactly
as described (6, 26). Also, lipoxygenase metabolites isolated from cells reacted
with GM-CSF and chemotactic factors were physicochemically identical to synthetic
material. The bioactivity determined by chemotaxis experiments as described (6) was
identical for synthetic and purified neutrophil-derived material (20-OH LTB4 and
LTB4).1284
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RP-HPLC of extracts from PMN . For each
chromatogram extracts from 8 X 107 cells were ana-
lyzed, using the program indicated in Materials and
Methods . The elution of the products was monitored at
270 nm from 0-23 min and at 238 nm from 23-30 min .
(a) The cells were incubated for 2 h with 2 pM GM-CSF,
then stimulated with 10-7 MC5a, and the reaction was
stopped with methanol 5 min after C5a addition . (b)
Neutrophils were preincubated in buffer alone for 2 h
and then stimulated with C5a as in A for 5 min . (c) Neu-
trophils were incubated for 2 hours and 5 minutes with
GM-CSF . (d) Cells were incubated in buffer alone for 2
hand 5 min . The elution position of purified lipoxygen-
ase metabolites are indicated with arrows . 1-ml fractions
of all chromatograms were analyzed by LTB4-RIA and
were negative except in A, where 922 pg LTB4 was
found at the elution position of LTB4 .
Results
Leukotriene Production of GM-CSF-primed PMN after Stimulation with C5a or
FMLP. Neutrophils (80 X 106 cells/batch) were incubated in a shaking water
bath at 37°C with (Fig. 1, a and c) or without (Fig . 1, b and d) 2 pM GM-CSF .
After 2 h the cells were challenged with C5a (10-7 M ; Fig . 1, a and b) or with
control buffer (Fig. 1, c and d) . 5 min after the addition of C5a, the cells and
supernatants were extracted and the products formed were analyzed by RP-
HPLC . Fig. 1 shows the typical chromatograms obtained in each experiment .
Fig. 1 d represents the analysis of an extract of cells without any stimuli added .
It can be seen that essentially no UV-absorbing material elutes at the retention
times of 20-000H LTB4 , 20-OH LTB4, and 5-Hete . Unfortunately, at high
detector sensitivity, UV-absorbing material was present just before and to a
lesser degree after the elution position of LTB4, rendering this region of the
chromatogram more difficult to interpret . However, further experiments with
RP-HPLC and SP-HPLC (6) and UV spectroscopy showed that none of these
UV absorbing peaks were due to oxidized AA metabolites containing a conju-
gated diene or triene structure . Furthermore, LTB4 RIAs performed from I-ml
fractions collected throughout the chromatogram were all negative (detection
limit 17, 5 pg), even when extracts of up to 108 cells were analyzed . Thus, rest-
ing PMN do not produce detectable lipoxygenase metabolites even when incu-
bated for prolonged periods . When PMN were incubated with GM-CSF or C5a
alone, the HPLC profile was identical to the control (Fig. 1, b and c), and no
LTB4 was detected in the fractions of the chromatograms by RIA . These results
indicate that none of the factors alone induces mobilization of endogenous AA
and metabolism through the lipoxygenase pathway . However, when PMN wereDAHINDEN ET AL.
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FIGURE 2. Detailed analysis of HPLC chromatograms at elution position for polar LTB4
metabolites, LTB4, and 5-Hete, using a Waters Associates photo-diode-arraydetector and the
spectrum index program. The lower chromatogram (B) shows the extract of 8 X 107 cells
preincubated in absence of GM-CSF during 2 h and then stimulated with FMLP (10-s M)
for 2.5 min. No lipoxygenase metabolites were detected and none of the UV-absorbing mate-
rials showed any indication of a spectrum typical of dienes or trienes. The upper chromato-
gram (A) shows a chromatogram of cells preincubated with 4 pM GM-CSF for 2 hand treated
with FMLP in an identical fashion. Of each peak the UV spectrum is shown using the spec-
trum index program and shows for the corresponding fractions the typical spectra of LTB4
metabolites, LTB4, and 5-Hete.
first primed with GM-CSF and then stimulated with C5a for 5 min, relatively
large amounts of 20-000H LTB4, 20-OH LTB4 and 5-Hete were formed by
the PMN (Fig. 1 a). No LTB4 could be detected by UV spectroscopy above back-
ground, but when the more sensitive RIA for LTB4 was performed, immuno-
reactive LTB4 was detected at the elution position of LTB4 (922 pg LTB4). Fig.
2 shows an example of an analysis of the most important regions of two chro-
matograms performed with the aid of a Waters Associates photo-diode-array1286
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detector and software (Spectrum index program) . The lower chromatogram
(Fig. 2 B) shows the analysis of extracts of 8 X 107 cells, stimulated with FMLP
(10-sM for 2.5 min) . None of the peaks obtained contained a spectrum repre-
senting conjugated trienes or dienes and no LTB4 was detected by RIA per-
formed in HPLC fractions . The upper part (A) shows details of the chromato-
gram and corresponding spectra of the UV peaks of the same cells, primed for
2 h with a supramaximal concentration of GM-CSF and subsequently stimulated
with FMLP (10" M) . Note the appearance of metabolites with a typical spec-
trum of the corresponding lipoxygenase metabolites eluting at the expected
retention times . When the reaction was stopped already 2.5 min after the addi-
tion of the chemotactic factor, as done in this example of an experiment, LTB4
was also demonstrable by UV absorbance in addition to RIA. The identity of the
a
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FIGURE 3 . Total of AA-derived trienes formed by PMN. Col-
umns show the sum of amounts of LTB4 (determined by RIA in
the corresponding HPLC fraction), 20-OH LTB4 and 20-COOH
LTB4 (both determined by integration values ofHPLC chromato-
grams), and represent the mean ± SEM of 21 experiments for
each condition . Cells were incubated for 2 h in buffer alone ({a),
or with 2-10 pM GM-CSF without addition of chemotactic factors
(CSF), or incubated with buffer for 2 h and then stimulated with
chemotactic factor, C5a (10-7 M) or FMLP (10-s M) (CF) . Under
these conditions amounts of trienes formed were below the detec-
tion limit, which is shown in these columns . (CSF -F CF) Cells were
CSF
0
￿
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preincubated for 2 h with GM-CSF and then stimulated with either
CF
￿
C5a or FMLP for 2.5-5min .
\
￿
induced leukotriene formation: The data represent
\
￿
the mean and ± SD of three experiments . The cells
(8 X 10 /batch) were incubated with 4 pM GM-CSF
for the time indicated and then stimulated with
FMLP (10- ' M) for 2.5 min . 20-OH LTB4 (-E--) and
20-000H LTB4 (-A-) were measured from integra-
tion values of HPLC experiments . LTB4 (-"-) was
measured with RIA from HPLC fractions at the elu-
tion position of LTB4 . The open symbols illustrate
the absence of the different lipoxygenase metabolites
in extracts of cells without addition of chemotactic
factor. Identical results are obtained with C5a as the
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FIGURE 5. Dose-response relationship
//
￿
of the priming effect of GM-CSF upon
the chemotactic factor induced leuko-
/ ,
￿
triene release: Each data point repre-
sents the values from a HPLC experi-
ment using 8 X 107 cells/batch. The
closed symbols represent data from
/
￿
cells stimulated with 10-s M FMLP for
5 min after 2 h of preincubation with
different concentrations of GM-CSF
~
￿
and the open symbols indicate the
1-no----------en--.---.. ...--. .-----------------...,o
￿
absence of metabolites formed when
cells were incubated with GM-CSF
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COOH LTB4.
different lipid metabolites as shown in Figs. 1 and 2, was also further confirmed
as indicated in Materials and Methods.
In a total of 21 HPLC experiments, each performed with extracts of 6-8 X
107 PMN, we found that PMN primed with GM-CSF and stimulated with che-
motactic factors produced 4.36 ± 0.95 (SEM) pM LTB4 and LTB4 metabolites/
106 PMN (Fig. 3). When LTB4 alone was measured by a combination of HPLC
and RIA, it was found that 2 .5 min after stimulation with C5a or FMLP of
primed PMN, 0.351 ± 0.065 (SEM) pM LTB4/106 cells (n = 13) was present
in such extracts, and 5 min after stimulation the level of LTB4 was 0.025 ±
0.004 (SEM) pM LTB4/106 cells (n = 8). There was no statistically significant
difference in the amount of products formed from primed cells subsequently
stimulated with either C5a or FMLP. No LTB4 metabolites (detection limit
0.056 ± 0.014 picomoles) could be detected in control incubations in the
absence of any stimuli or with GM-CSF or C5a and FMLP alone (Fig. 3), and
no immunoreactive LTB4 was detected in the HPLC fractions (detection limit of
HPLC + RIA 0 .008 pM/106 cells) .
Time Course of the Priming Effect of GM-CSF.
￿
Fig. 4 shows that a relatively
prolonged incubation of PMN with GM-CSF is necessary to produce the
observed change in the lipid metabolism of cells stimulated with chemotactic
factors. LTB4 and LTB4 metabolites are reproducibly detected after a 1-h incu-
bation of PMN with GM-CSF but a maximal enhancement occurs only after 2
h. At 3 h the effect tends to decline again. An identical time course is obtained
regardless of whether C5a or FMLP is used as the second signal (data not
shown). In two of four experiments we observed a small production of LTB4
measured by RIA already after a priming period of 30 min, but LTB4 metabo-
lites could not be identified with certainty by HPLC . No lipoxygenase metabo-
lites were found in the absence of a second trigger with chemotactic factors over
the whole incubation period (Fig. 4, open symbols). Thus, the time required to1288
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FIGURE 6 . LTB4 formation measured
by RIA from cells stimulated with 10 -6
M FMLP for 2.5 min after preincuba-
tion with various concentrations of GM-
CSF during 2 h . Data shown represent
mean ± SEM of two experiments per-
formed in triplicates. No further
increase of LTB4 was observed with
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optimally induce LTB4 synthesis in PMN is similar to the time course for the
enhancement of FMLP induced superoxide (02_) production (20) .
Dose-Response ofGM-CSF-induced PrimingforLeukotriene Synthesis.
￿
PMN were
incubated with different amounts of GM-CSF for an optimal time period of 2 h
and were then stimulated for 5 min with 10-6 M FMLP before extraction and
HPLC analysis . The results of such experiments shown in Fig. 5 indicated that
already at 2.5 U/106 PMN GM-CSF (3 X 10 -" M), significant amounts of 20-
000H LTB4 and 20-OH LTB4 could be identified by HPLC . The effect was
optimal with 80 U/106 PMN (10-" M) and the half-maximal response was
between 20 and 40 U/106 PMN (2.5-5 X 10 - '° M) . LTB4 metabolites seemed
even to be produced below 2.5 U/106 PMN, but could not be unequivocally
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FIGURE 7 . The time course of lipoxygenase metab-
0
r 1.0 olite formation after stimulation with 10-6 M FMLP . a ro \\ The cells were first incubated with 2 pM GM-CSF for
0.5 2 h . Each data point represents the results from a
/,; HPLC experiment using extracts from 6 X 10 7 cells
per experiment . (-"-) LTB4 ; (--&-) 20-OH LTB4;
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HPLC-analysis of LTB4 and LTB4 metabolites formed
j
￿
after stimulation with C5a and preincubation for 2 h with GM-
CSF. The data represent examples of a typical experiment using
extracts from 6 X 107 cells for each chromatogram. Arrows indi-
cate the elution position of leukotriene standards: 1, 20-COOH
LTB4; 2, 20-OH LTB4; 3, 6-trans LTB4; 4, LTB4. The reaction was
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22
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stopped after C5a addition at 0, 2.5, 5, and 10 min using 2 vol of
Retention rime
￿
methanol. PGB2 was used as an internal standard (PGB2).
identified with UV spectroscopy. When LTB4 was measured with RIA, however,
significant production of LTB4 could even be found at 0.8 U/106 PMN (10 pM),
as shown in Fig. 6.
Time Course of the Mediator Profile from GM-CSF-primed PMN Stimulated with
Chemotactic Factors. The induction of the synthesis of lipoxygenase products in
GM-CSF-preincubated PMN occurs very rapidly upon stimulation with C5a or
FMLP. Figs. 7 and 8 show that LTB4 formed under these conditions is metab-
olized almost as rapidly as it is formed into 20-OH LTB4 and more slowly into
20-000H LTB4. Only within 2 .5 min after the addition of FMLP (Fig. 7) or
C5a (Fig. 8) is it possible to detect LTB4 by UV absorbance in HPLC chroma-
tograms and already at this early time point the major metabolites are 20-OH
LTB4 and 20-000H LTB4. These results are in contrast to the mediator profiles
found shortly after calcium ionophore stimulation, where LTB4 is formed in
such large amounts as to exceed the capacity of the St-oxidizing enzymes within
the cells. Already 5 min after the addition of chemotactic factors, LTB4 can only
be demonstrated when extracts of very large numbers of cells are analyzed by a
combination of HPLC and RIA.1290
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Discussion
Our data demonstrate a dramatic effect ofGM-CSF upon chemotactic factor-
induced lipid metabolism in human PMN. Neither GM-CSF nor C5a or FMLP
alone seems to induce a measurable generation of leukotrienes in PMN tested
at any time point after the addition of the factor, under incubation conditions
used in this study . PMN preincubated under optimal conditions with GM-CSF,
however, produce substantial amounts of these important lipid mediators after
stimulation with C5a or FMLP, albeit to a lesser extent than ionophore-stimu-
lated PMN (9, 10, 26) . Our data indicate that the synthesis of lipoxygenase
metabolites from endogenous AA pools can be initiated through receptor-
mediated processes by the appropriately timed combination of biological soluble
inflammatory mediator peptides . In our hands, this is the first example of leu-
kotriene synthesis in PMN induced exclusively with peptidic biomolecules . The
only other stimuli found so far to induce the synthesis of lipoxygenase metabo-
lites from endogenous AA in PMN were calcium ionophore (9, 10), a combi-
nation of phorbol esters with calcium ionophore or chemotactic factors (12, 29,
30), and phagocytosis (31) . Claims that chemotactic factors (32) induce leuko-
triene synthesis directly and in the absence of exogenous AA could so far not
be reproduced when highly purified neutrophil preparations were used, in
agreement with more recent reports of other investigators (33) .
Our results may be related to the recently reported effect of GM-CSF on
LTC4 synthesis and cytotoxicity in eosinophils (23) . These authors observed a
significant, but variable, enhancement by GM-CSF of leukotrieneC4 synthesis in
eosinophils stimulated with a suboptimal dose of calcium ionophore A 12387 .
Although these results cannot be compared directly with our findings, since cal-
cium ionophores are by themselves very potent stimuli for leukotriene synthesis,
it seems likely to us that the underlying mechanism of this enhancement by GM-
CSF is identical to the priming effect in PMN shown here . Our findings confirm
and extend the recently proposed important role ofGM-CSF as an inflammatory
mediator and modulator ofPMN and other inflammatory effector cells (19-24,
34-36), in addition to its well-recognized function as a growth factor of myeloid
precursor cells (13) . Other cytokines (TNF-a, TNF-0 and IFN-y) also enhance
PMN functions (24, 37). The enhancement of antibody-mediated cytotoxicity is
even stronger for TNF-a than for GM-CSF (24, 37) and TNFs seem to directly
stimulate a respiratory burst of PMN (38) . However, despite extensive experi-
ments, we did not find leukotriene production in PMN stimulated with TNF-a
alone or in a combination with chemotactic factors over a wide range of con-
centrations and incubation times (our unpublished results) .
The biochemical mechanism by which LTB4 is formed in PMN stimulated with
GM-CSF and chemotactic factor is not known . Our previous studies (10) have
shown that the second messengers formed after the interaction of C5a with its
neutrophil receptors are sufficient to activate the lipoxygenase, but not enough
endogenous AA is liberated and/or available at the same time the lipoxygenase
is transiently active . The activation of the lipoxygenase in PMN by chemotactic
factors occurs rapidly and parallels the transient elevation in [Ca21], levels (10) .
Interestingly, leukotriene generation of GM-CSF primed PMN proceeds equally
rapidly and transiently after stimulation with chemotactic factors as previouslyDAHINDEN ET AL.
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shown for metabolism of exogenous AA. These observations are consistent
with the hypothesis that GM-CSF does not modulate the activation of the li-
poxygenase, but rather enhances the rapid release and availability of AA through
the activation of phospholipase A2 or phospholipase C/diacylglycerol
lipase.
Lipoxygenase metabolites are formed very rapidly after stimulation of GM-
CSF-primed PMN with chemotactic factors. LTB4 is metabolized by the SZ oxi-
dation pathway almost as rapidly as it is formed, and already 2.5 min after stim-
ulation with FMLP or C5a the major products present were 20-OH LTB4 and
20-COOH LTB4. Obviously, SZ oxidation is a very efficient metabolic pathway in
human PMN; and LTB4 is only the major product when very large amounts of
LTB4 are formed, exceeding the capacity of the S2-oxidizing enzymes, as for
example in the case of calcium ionophore-stimulated cells. The mediator profile
of lipoxygenase products shown in this study might in fact more closely resemble
the conditions found in vivo than results obtained with artificial stimuli. We pre-
viously found that 20-OH LTB4 is a potent chemotactic factor with similar activ-
ity as LTB4 itself and proposed that this more hydrophilic mediator could play
an important role in inflammation (6, 39). Our results in this study further sup-
port this hypothesis. The predominance of polar LTB4 metabolites also clearly
shows the importance of an analysis of these products in order to estimate more
accurately the activity of the lipoxygenase pathway.
The priming effect upon lipid metabolism occurs at physiologically relevant
concentration, commonly found in supernatants of stimulated mononuclear
cells. Both the concentration dependence and the time required for optimal
priming are very similar to the reported enhancement of FMLP-induced super-
oxide production (20), which is consistent with the hypothesis that an identical
mechanism underlies both effects. It has been recently shown (34) that GM-CSF
results in an increased number of low-affinity FMLP receptors, and the authors
proposed that this could be responsible for the enhancement of 02- production.
The possibility exists that this change in receptor affinity might also be respon-
sible for the priming of leukotriene synthesis. However, GM-CSF also primes
C5a responses and enhances 02- production in an identical manner (Dahinden,
C. A. unpublished data), and up to now only a single class of high-affinity C5a
receptors has been defined in PMN. Thus, the lipid mediators formed might also
have an intracellular or autocoid role and in fact be responsible for the enhance-
ment of 02- production. Indeed, the lipid mediators are formed at the same
time 02- is generated after FMLP stimulation, and several lipids like 5-Hete,
LTB4, and platelet-activating factor enhance effects of FMLP and C5a even at
low concentrations, which are by themselves not stimulatory (40, 41, and our
unpublished results) . Clearly, more work is required to establish the relationship
between the enhancement of 02- production and leukotriene release.
In summary, we find that GM-CSF qualitatively changes the lipid mediator
profile of PMN stimulated with chemotactic factors. These lipid mediators
formed might be important in amplifying and modulating inflammatory reac-
tions or might also result in a change of effector cell functions. Our study fur-
ther documents the possible central role of GM-CSF as an inflammatory
mediator.1292
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Summary
Neutrophils (PMN) preincubated with recombinant human granulo-
cyte/macrophage colony-stimulating factor (rhGM-CSF) for 2 h and then stim-
ulated with the chemotactic factors, C5a or FMLP, produce substantial amounts
of the lipoxygenase products 5-Hete, LTB4 , and St-oxidised LTB4 metabolites
(4.36 ± 0.95 (SEM) pM (n = 21) LTB4 and LTB4 metabolites/10 6 PMN) . No
lipoxygenase metabolites are detected by HPLC and RIA if purified PMN are
stimulated by either GM-CSF or chemotactic factors in the absence of exoge-
nous arachidonate . The priming effect of GM-CSF upon chemotactic factor
induced generation of lipid mediators is a relatively slow process, clearly evident
after 1 h and optimal after 2 h . Leukotriene generation is measurable with 0.8
U GM-CSF/106 PMN and is maximal with 80 U (10 -"-10 -9 M) . Upon activa-
tion of primed PMN with chemotactic factors, leukotriene synthesis is induced
very rapidly. Already 2.5 min after activation the major lipoxygenase metabolites
present are 20-OH LTB4 and 20-000H LTB4 . Our study shows that the syn-
thesis of lipoxygenase metabolites from endogeneous AA can be initiated in
PMN through receptor mediated processes by the appropriately timed combi-
nation of biological soluble inflammatory mediator peptides . Furthermore, these
results indicate that GM-CSF not only enhances effector cell functions but can
qualitatively change the mediator profile formed after activation with a second
triggering signal . Such a mechanism might be important in amplifying inflam-
matory responses . Alternatively, lipid mediators formed might also have an
intracellular or autocoid role and be responsible for the enhancement of other
PMN functions like oxygen radical release .
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